Tomas Berl
Physician · University of Colorado School of Medicine
Credentials: · ·
History
Nephrology
Internal Medicine
Research
New England Journal of Medicine · 2001 · 4,552 citations
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia
New England Journal of Medicine · 2006 · 881 citations
Systematic review or meta-analysis · European Heart Journal · 2010 · 730 citations
36 papers
10 papers
10 papers
- GA
8 papers · 1 as a resident
- SL
8 papers
- WH
8 papers · 3 as a fellow
- AM
7 papers
7 papers
Grants
- 1983–2013
Renal and Electrolyte Disease and Hypertension
National Institute of Diabetes and Digestive and Kidney Diseases · T32
Contact PI · $3.5M · University of Colorado Denver
- 1997–2009
Vasopressin and Hyperosmolality: Regulation, Adaptation
National Institute of Diabetes and Digestive and Kidney Diseases · P01
Project lead · $2.9M · University of Colorado Denver
- 2004–2009
Osmoregulated Proteins in the Inner Medulla
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.2M · University of Colorado Denver
- 1997–1999
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $175.3K · University of Colorado Denver